Annals of Internal Medicine, 2015
Michael Rosenblatt et al.


Read the Full Article

This commentary discusses the benefits and risks of data sharing from the perspective of persons with experience in academic medicine, government, and medical publishing, as well as the pharmaceutical industry.

biotechnology clinical research human subjects research privacy regulation